The Latest on TB Research
See below the latest articles and publication on TB and HIV research.
Recording isoniazid preventive therapy delivery to children: operational challenges.
Van Wyk SS, Hamade H, Hesseling AC, Beyers N, Enarson DA, Mandalakas AM.
Int J Tuberc Lung Dis. 2010 May;14(5):650-3.
Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients.
Hesseling AC, Walzl G, Enarson DA, Carroll NM, Duncan K, Lukey PT, Lombard C, Donald PR, Lawrence KA, Gie RP, van Helden PD, Beyers N.
Int J Tuberc Lung Dis. 2010 May;14(5):560-70.
South African TB nurses' experiences of provider-initiated HIV counseling and testing in the Eastern Cape Province: a qualitative study.
Pope DS, Atkins S, DeLuca AN, Hausler H, Hoosain E, Celentano DD, Chaisson RE.
AIDS Care. 2010 Feb;22(2):238-45.
Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting.
van Halsema CL, Fielding KL, Chihota VN, Russell EC, Lewis JJ, Churchyard GJ, Grant AD.
AIDS. 2010 Apr 24;24(7):1051-5.
Recurrent tuberculosis: relapse, reinfection, and HIV.
Chaisson RE, Churchyard GJ.
J Infect Dis. 2010 Mar;201(5):653-5. No abstract available.
Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil.
Cavalcante SC, Durovni B, Barnes GL, Souza FB, Silva RF, Barroso PF, Mohan CI, Miller A, Golub JE, Chaisson RE.
Int J Tuberc Lung Dis. 2010 Feb;14(2):203-9.
Incidence of tuberculosis and HIV and progression of silicosis and lung function impairment among former Basotho gold miners
Park HH, Girdler-Brown BV, Churchyard GJ, White NW, Ehrlich RI.
Am J Ind Med. 2009 Dec;52(12):901-8.
HIV infection does not affect active case finding of tuberculosis in South African gold miners
Lewis JJ, Charalambous S, Day JH, Fielding KL, Grant AD, Hayes RJ, Corbett EL, Churchyard GJ.
Am J Respir Crit Care Med. 2009 Dec 15;180(12):1271-8
Screening and preventive therapy for tuberculosis
Marais BJ, Ayles H, Graham SM, Godfrey-Faussett P.
Clin Chest Med. 2009 Dec;30(4):827-46, x
The fourth I: scaling up implementation of collaborative TB-HIV activities to protect vulnerable mothers and infants
Gie RP, Beyers N.
Int J Tuberc Lung Dis. 2009 Dec;13(12):1443.
Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population
Kariminia A, Sharifnia Z, Aghakhani A, Banifazl M, Eslamifar A, Hazrati M, Ramezani A.
Evaluation of the Effect of Treatment of Latent Tuberculosis Infection on QuantiFERON-TB Gold Assay Results
Pollock N, Kashino S, Napolitano D, Sloutsky A, Joshi S, Guillet J, Wong M, Nardell E, Campos-Neto A.
Biomarkers for tuberculosis disease activity, cure, and relapse
Wallis R, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S, Zumla A.